enGene Holdings Inc. (ENGN) vs Genelux Corporation (GNLX)

A side-by-side comparison of enGene Holdings Inc. and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ENGN

enGene Holdings Inc.

$121M

$1.80HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT

GNLX

Genelux Corporation

$115M

$2.56HealthcareDelayed quote: Oct 6, 2026, 10:30 AM EDT

Total return — ENGN vs GNLX

growth of $100 · dividends reinvested · last 3y

ENGN -90.7% (-54.6%/yr)GNLX -83.6% (-45.2%/yr)GNLX compounded faster over this window

ENGN GNLX

ENGN vs GNLX: by the numbers

•ENGN is the larger company ($121M vs $115M market cap).
•Both run net losses; ENGN's is the smaller (0.00% vs -422412.50% net margin).

Metrics side by side

Valuation

Metric	ENGN	GNLX
P/S ratio	N/A	14320.91
P/B ratio	0.52	7.11

Profitability

Metric	ENGN	GNLX
Gross margin	0.00%	-7075.00%
Operating margin	0.00%	-415175.00%
Net margin	0.00%	-422412.50%
ROE	-2.13%	-209.73%
ROIC	-1.78%	-192.18%

Go deeper

Full ENGN analysis Full GNLX analysis Interactive comparison tool

Dig into the metrics

enGene ROE Genelux ROE enGene operating margin Genelux operating margin enGene revenue growth Genelux revenue growth enGene free cash flow Genelux free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.